<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 24-mer (antisense) phosphorothioate oligonucleotide (ODN) corresponding to the codons 2-9 of the c-myb gene was evaluated for its effects on the growth of a human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line (Raji) in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Raji cells incubated with different concentrations of c-myb antisense ODN (5-15 mu g/ml) for 24-72 h showed a significant dose-dependent decrease in growth </plain></SENT>
<SENT sid="2" pm="."><plain>The same concentrations of control (sense) or scrambled c-myb phosphorothioate ODNs did not inhibit Raji cell growth </plain></SENT>
<SENT sid="3" pm="."><plain>The c-myb antisense ODN, but not the control ODNs, significantly decreased c-myb <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels in treated cells as determined by RT-PCR </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, the c-myb antisense ODN induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of Raji cells as demonstrated by i) flow cytometry to enumerate the A(o) (apoptotic cell population) population of <z:chebi fb="0" ids="51240">propidium iodide</z:chebi> stained cells; ii) electron microscopy to evaluate the cell <z:mp ids='MP_0000002'>morphology</z:mp>; and iii) DNA fragmentation pattern </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, an antisense c-myb ODN causes significant growth inhibition of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, and one mechanism of growth inhibition is the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, antisense c-myb ODN did not reduce CFU-GM or BFU-e colony-forming ability of <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic stem/progenitor cells </plain></SENT>
<SENT sid="7" pm="."><plain>Because the inhibition is sequence-specific and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell selective, evaluation of the therapeutic effects of c-myb antisense ODN against Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is warranted </plain></SENT>
</text></document>